Valuation: Diaceutics PLC

Market Cap 112M 149M 130M 122M 210M 14.25B 215M 1.44B 562M 7.08B 560M 549M 24.41B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 104M 139M 121M 113M 195M 13.26B 200M 1.34B 523M 6.59B 521M 510M 22.71B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.77x
Free-Float
71.95%
Yield 2026 *
-
Yield 2027 * -
1 day+4.35%
1 week-0.38%
Current month-9.59%
1 month-8.97%
3 months-23.48%
6 months-20.00%
Current year+3.12%
1 week 125
Extreme 125
135
1 month 125
Extreme 125
148
Current year 125
Extreme 125
180
1 year 125
Extreme 125
180
3 years 82
Extreme 82
180
5 years 74
Extreme 74
180
10 years 74
Extreme 74
195
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Date Insider Type Main position Quantity % Market Cap.
5/5/26 A Buy

Director

90 0.0001%
5/5/26 A Buy

Chief Financial Officer

90 0.0001%
5/5/26 A Free

Chief Financial Officer

90 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+4.35%-0.38%-1.12%+36.79% 142M
-12.65%-31.67%+180.99%+682.58% 43.45B
-1.15%+8.11% - - 6.95B
-4.66%-1.01% - - 3.36B
+0.35%-5.94%-1.42%+20.35% 3.2B
+0.75%-7.94%+7.71%+104.41% 3.05B
+2.55%+2.85%-36.85%-40.71% 1.28B
+1.56%-0.31%-15.98%-39.42% 1.28B
+0.33%-14.63%-42.15%+37.43% 1.22B
Average +0.56%-0.79%+13.03%+114.49% 7.1B
Weighted average by Cap. +0.41%+2.40%+144.76%+559.21%

Financials

2026 *2027 *
Net sales 46.72M 62.45M 54.44M 50.79M 87.68M 5.96B 89.74M 602M 235M 2.96B 234M 229M 10.2B 56.34M 75.31M 65.65M 61.25M 106M 7.18B 108M 726M 284M 3.57B 282M 277M 12.3B
Net income -1.1M -1.47M -1.28M -1.2M -2.06M -140M -2.11M -14.18M -5.54M -69.68M -5.51M -5.4M -240M 1.5M 2.01M 1.75M 1.63M 2.82M 191M 2.88M 19.34M 7.55M 95.02M 7.52M 7.36M 328M
Net Debt -7.78M -10.4M -9.07M -8.46M -14.6M -992M -14.95M -100M -39.15M -493M -39M -38.19M -1.7B -12.1M -16.17M -14.1M -13.15M -22.7M -1.54B -23.24M -156M -60.88M -766M -60.63M -59.37M -2.64B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
29/07/26 GBX 132.00 +4.35% 4,021,933
28/07/26 GBX 126.50 -1.17% 56,979
27/07/26 GBX 128.00 -0.78% 64,496
24/07/26 GBX 129.00 +0.39% 78,550
23/07/26 GBX 128.50 -2.65% 75,489
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.265GBP
Average target price
2.130GBP
Spread / Average Target
+68.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXRX Stock